These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37462204)

  • 1. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
    Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
    Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
    Satou A; Banno S; Kohno K; Takahara T; Takahashi E; Nobata H; Iwagaitsu S; Watanabe D; Hanamura I; Takami A; Ito Y; Nakamura S; Tsuzuki T
    Pathology; 2021 Aug; 53(5):595-601. PubMed ID: 33618861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the┬áliterature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
    Yasuda H; Ando J; Yoshida S; Ota Y; Komatsu N; Ando M
    Intern Med; 2023 Feb; 62(4):601-604. PubMed ID: 35793959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
    World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
    Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
    Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
    Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
    Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
    Omameuda T; Miyato H; Sata N; Lefor AK
    Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
    Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
    J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
    Shiraiwa S; Kikuti YY; Carreras J; Hara R; Aoyama Y; Ogiya D; Suzuki R; Toyosaki M; Ohmachi K; Ogawa Y; Kawada H; Sato S; Nakamura N; Ando K
    J Clin Exp Hematop; 2020 Dec; 60(4):159-168. PubMed ID: 33148934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Tokuhira M; Tamaru JI; Kizaki M
    J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
    Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
    J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.
    Ravi PY; Sigamani E; Jeelani Y; Manipadam MT
    Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
    Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.
    Horie N; Kawano R; Kaneko T; Shimoyama T
    Aust Dent J; 2015 Sep; 60(3):408-11. PubMed ID: 25302816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
    He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
    Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.